Titre:
  • Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202).
Auteur:Lenz, Oliver; Vijgen, Leen; Berke, Jan Martin; Cummings, Maxwell D; Fevery, Bart; Peeters, Monika P.; De Smedt, Goedele; Moreno, Christophe; Picchio, Gaston
Informations sur la publication:Journal of hepatology, 58, 3, page (445-451)
Statut de publication:Publié, 2013-03
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antiviral Agents -- therapeutic use
Genotype
Hepacivirus -- classification -- drug effects -- genetics
Hepatitis C -- drug therapy -- virology
Heterocyclic Compounds, 3-Ring -- pharmacology -- therapeutic use
Humans
Mutation
Polymorphism, Genetic
RNA, Viral -- blood
Sulfonamides -- pharmacology -- therapeutic use
Viral Nonstructural Proteins -- antagonists & inhibitors -- genetics
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0168-8278
info:doi/10.1016/j.jhep.2012.10.028
info:pii/S0168-8278(12)00829-X
info:scp/84874105854
info:pmid/23142061